Market Place
Sourcing Support
Acquired approval for manufacturing and marketing generic drugs
15 Aug 2024 //
PRESS RELEASE
Tiefenbacher Successfully Launches Generic Version Diabetis Med Vildagliptin
08 Sep 2022 //
PRESS RELEASE
Accord Healthcare Vildagliptin/Metformin HCL Receives Approval in Europe
17 Jun 2022 //
EMA
Glenmark Pharma launches FDC drug for type 2 diabetes
26 Oct 2021 //
PHARMABIZ
Glenmark becomes the first company to launch Remogliflozin + Vildagliptin
29 Dec 2020 //
PRNEWSWIRE
Cipla acquires brand, trademark for anti-diabetic drug Vysov in India
16 Dec 2019 //
BUSINESS-STANDARD
Cadila Healthcare gains 4% on launch of anti-diabetic tablet in India
12 Dec 2019 //
MONEYCONTROL
Panacea Biotec launches diabetes drug in India
11 Dec 2019 //
BIOSPECTRUMASIA
Panacea Biotec launches ViLACT brand in India to treat uncontrolled type 2 DM
10 Dec 2019 //
PHARMABIZ
USV in talks with Novartis to buy Jalra Trademark for Rs. 200 Crore
10 Dec 2019 //
ECONOMIC TIMES
Eris Lifesciences acquires trademark Zomelis from Novartis AG for $13 mn
04 Dec 2019 //
BUSINESS STANDARD
Morepen Labs introduces three new API drugs
15 Oct 2019 //
PHARMABIZ
Novartis VERIFY ph IV study in type 2 diabetes demonstrate clinical benefits
19 Sep 2019 //
PHARMABIZ
FDA raids traders ‘diverting’ drugs meant for defence
10 Feb 2019 //
ECONOMIC TIMES
Novartis restrains local pharma Cos from making patent diabetes drug
07 Aug 2018 //
TIMES OF INDIA
Novartis, Abbott targeted by Indian watchdog over allegations of price collusion
14 Dec 2017 //
PHARMAFILE
CCI starts probe on alleged price fixing of key anti diabetic drugs
13 Dec 2017 //
ECONOMIC TIMES
Anti-diabetic drug cartel issue reaches CCI, Health Ministry
24 Mar 2017 //
ECONOMIC TIMES
NeoBiocon partners Novartis to launch diabetes drugs in UAE
09 Dec 2015 //
ECONOMIC TIMES
Vildagliptin for Type 2 Diabetes: No Suitable Data for Combination with Sulfonylurea
10 Mar 2015 //
SCIENCE DAILY
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.